Skip to main content
Clinical Trials/NCT03666377
NCT03666377RecruitingNot Applicable

The Impact of Chewing Gum on Postoperative Ileus in Children Who Undergo Abdominal Surgery: a Prospective, Randomized, Controlled Pilot Study

University of Manitoba1 site in 1 country140 target enrollmentStarted: December 1, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
140
Locations
1
Primary Endpoint
Composite outcome: first flatus, first bowel movement, first solid oral intake (any)

Study Overview

Brief Summary

Traditional postoperative care has been challenged recently to improve and speedup recovery (including the return of bowel function) such that patients can be discharged to home more quickly. This approach includes earlier mobilization of the patient, and introducing solid food sooner. Additionally, there is evidence in adults to suggest that "sham feeding" by chewing gum may also speed up bowel recovery so the patient may tolerate a solid diet earlier.

The aim of this study is to determine if gum chewing can enhance bowel recovery in children who undergo abdominal surgery.

Detailed Description

After intestinal surgery, many patients suffer from a "postoperative ileus" (POI). The cause is multifactorial and can be attributed to surgery itself, the lingering effect of the anesthetic, the use of narcotics and decreased mobility of the patient.

An ileus can delay the time to full diet, thus lengthening the hospital stay of the patient - sometimes up to several weeks.

There is evidence that early drinking/eating and increased mobility may accelerate the return of bowel function. "Fast-tracking" is well documented in the adult literature; protocols have been put in place to enhance GI tract recovery and thus decrease the morbidity of a prolonged hospital stay and ileus. "Fast-tracking" has been done in pediatric patients but not in a large RCT for abdominal surgery.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
4 Years to 17 Years (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Children more than or equal to 4 years of age
  • •Children who undergo abdominal surgery (both laparoscopic or open)
  • •Children who have an expected postoperative length of stay more than 24 hours

Exclusion Criteria

  • •Children who are less than 4 years of age
  • •Children who are unable to chew gum/swallow (e.g. intubated, decreased level of consciousness, cognitive or physical disability)
  • •Children or their parents are not willing to sign consent
  • •Children or their parents are unable to follow directions regarding gum chewing,
  • •Children who have a GI dysmotility disorder (e.g. chronic intestinal pseudo-obstruction)

Arms & Interventions

No gum chewing

No Intervention

Usual pharmacologic treatment and post-operative care (e.g. daily visits by surgical team, antibiotics where appropriate, mobilization, advancement of diet as tolerated). Analgesia and anti-emetics will be provided (both oral and intravenous) as needed.

Gum chewing

Experimental

Usual pharmacologic treatment and post-operative care (e.g. daily visits by surgical team, antibiotics where appropriate, mobilization, advancement of diet as tolerated). Analgesia and anti-emetics will be provided (both oral and intravenous) as needed.

Intervention: 1 piece of sugarless gum to be chewed three times daily for 1 hour each.

Intervention: Gum chewing (Other)

Outcomes

Primary Outcomes

Composite outcome: first flatus, first bowel movement, first solid oral intake (any)

Time Frame: From time of leaving the operating room (time zero) until the time of event (first bowel movement, first flatus, first oral intake) or date of death of any cause, whichever comes first, assessed up to 30 days, measured in hours

Documented by nurse, patient or caregiver

Secondary Outcomes

  • Readmission(From day of discharge (time zero) until the time of event (day of readmission) or date of death of any cause, whichever comes first, assessed up to 30 days, measured in days)
  • Swallowing/aspiration of gum(From day of entering the operating room (time zero) until the time of event (swallowing/aspiration of gum) or date of death of any cause, whichever comes first, assessed up to 30 days, measured as yes/no)
  • Need for prokinetic/anti-reflux medication(From time of leaving the operating room (time zero) until the time of event (ordering of prokinetic/anti-reflux medication) or date of death of any cause, whichever comes first, assessed up to 30days, measured in hours)
  • Length of stay(From day of entering the operating room (time zero) until the time of event (day of discharge) or date of death of any cause, whichever comes first, assessed up to 30 days, measured in days)
  • Allergic reaction/adverse reaction to gum(From day of entering the operating room (time zero) until the time of event (allergic reaction/adverse reaction to gum) or date of death of any cause, whichever comes first, assessed up to 30 days, measured as yes/no)
  • Re-operation(From day of entering the operating room (time zero) until the time of event (Re-operation) or date of death of any cause, whichever comes first, assessed up to 30 days, measured as yes/no)
  • Narcotic use(From time of leaving the operating room (time zero) until the time of event (ordering of narcotic medication) or date of death of any cause, whichever comes first, assessed up to 30days, measured in hours)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Anna Shawyer

Pediatric Surgeon

University of Manitoba

Study Sites (1)

Loading locations...

Similar Trials